PMG
PRPH

ProVise Management Group’s ProPhase Labs PRPH Stock Holding History

ProVise Management Group’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,208
Closed -$213K – 361
2022
Q4 		$213K Buy
+2,208
New +$239K 0.02% 297

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ProVise Management Group's PRPH Position: Q1 2023 in Review

ProVise Management Group sold out of ProPhase Labs (PRPH) in Q1 2023, closing a stake of 2,208 shares — an estimated $213K sold.

ProVise Management Group first reported a position in PRPH in Q4 2022 and held it in 1 quarter. The position peaked at $213K in Q4 2022. 39 funds tracked by Wall St. Rank hold PRPH as of Q1 2023.

  • ProVise Management Group reported no remaining ProPhase Labs position as of Q1 2023 after selling out during the quarter.
  • ProVise Management Group sold 2,208 ProPhase Labs shares in Q1 2023, an estimated $213K.
  • ProVise Management Group first reported a position in ProPhase Labs in Q4 2022 and held it in 1 quarter.
  • ProVise Management Group's ProPhase Labs position peaked at $213K in Q4 2022.
  • 39 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2023.

Based on ProVise Management Group's 13F filing for Q1 2023, filed 8 May 2023.